Senator Hassan Kicks Off National Health Center Week at Lamprey Health Care in Nashua
NASHUA – Senator Maggie Hassan today kicked off National Health Center Week at Lamprey Health Care, where she spoke with clinic directors and practitioners from Lamprey Health Care and Greater Nashua Mental Health about the skyrocketing cost of prescription drugs, as well as her work to help advance major bipartisan legislation to lower prescription drug costs.
Senator Hassan also heard more from clinic officials about the InteGreat program through Lamprey Health Care and Greater Nashua Mental Health. The program helps patients seamlessly receive primary care and mental health care at both facilities.
“Community health centers in New Hampshire are incredibly important to the well-being of thousands of Granite Staters who rely on these centers for their primary and preventative care,” Senator Hassan said. “I want to thank the staff at Lamprey Health Care and Greater Nashua Mental Health for all the work that they do to support some of our most vulnerable citizens, including those struggling with substance misuse. It was great to hear more about their work to integrate behavioral and primary care, and I will continue working to ensure that centers across New Hampshire have the support they need to continue their vital work.”
The discussion also focused on the rising cost of prescription drugs and the impact it has on patients. “I hear far too often from people across the state that skyrocketing prescription drug costs are untenable,” Senator Hassan said. “I am working across the aisle to take action on this issue – just recently, the Senate Finance Committee that I serve on moved forward with bipartisan legislation to begin to take on big pharma and lower prescription drug prices. I am hopeful that we will get this important bill across the finish line.”
The bipartisan Prescription Drug Pricing Reduction Act that Senator Hassan helped to pass in the Senate Finance Committee would enact a cap on out-of-pocket prescription drug costs for Medicare Part D beneficiaries and crack down on pharmaceutical companies that raise drug prices higher than inflation. The bill would also help put downward pressure on prescription drug costs for all consumers.
Next Article Previous Article